• Aurisco Pharmaceutical Co., Ltd.

    Focus on the R&D, production and sales of complex APIs and preparations, and CRO/CDMO of oligonucleotide drugs

  • Aurisco Pharmaceutical Co., Ltd.

    Aurisco has been deeply involved in the pharmaceutical industry for more than 20 years and commits itself to continuous technological innovation. Today the company is playing a leading role in China in the field of complex synthesis, synthetic biology, photochemistry etc. And has become a long-term partner of the well-known pharmaceutical companies worldwide

Hot news

  • AI-Enabled Future Pharmacy Conference

    "Future Pharmaceutical Industry-University-Research Development Forum under AI Empowerment and Pharmaceutical Discipline Development Conference of East China Normal University"

  • Aurisco will attend DCAT Week 2024 18-21 March

    Aurisco will be in New York City during the DCAT Week from 18th to 21st March, 2024, hosting its meeting at the Lotte Palace Hotel.

  • Aurisco will attend OPT USA 2024

    Aurisco will be attending the OPT Congress in Boston, USA from 13th to 14th March, 2024.

About UsAurisco Stock code:605116
Established in 1998, Aurisco is an innovative pharmaceutical company engaged in research, manufacturing and marketing of specialty APIs, formulations as well as CMO service. With the registration address in Zhejiang Tiantai , the company has operation center in Shanghai and subsidiaries in USA, Portugal, Brazil,Yangzhou,Hangzhou and Tianjing. Aurisco has been deeply involved in the pharmaceutical industry for more than 20 years and commits itself to continuous technological innovation. Today the company is playing a leading role in China in the field of complex synthesis, synthetic biology, photochemistry etc. And has become a long-term partner of the well-known pharmaceutical companies worldwide. Complete quality system,sufficient production capaciy and globe sales network enable the company to provide high-quality products and efficient service to our customers around the world.

3

Manufacturing Facilities

6

R & D Centers

240+

Scientists

400+

Partnerships

1600+

Staff members
  • 19 2024-01

    AI-Enabled Future Pharmacy Conference

    "Future Pharmaceutical Industry-University-Research Development Forum under AI Empowerment and Pharmaceutical Discipline Development Conference of East China Normal University"

  • 16 2024-01

    Aurisco will attend DCAT Week 2024 18-21 March

    Aurisco will be in New York City during the DCAT Week from 18th to 21st March, 2024, hosting its meeting at the Lotte Palace Hotel.

  • 16 2024-01

    Aurisco will attend OPT USA 2024

    Aurisco will be attending the OPT Congress in Boston, USA from 13th to 14th March, 2024.

  • 15 2023-11

    DDL UK 2023

    We will be attending the DDL 2023 – Drug Delivery to the Lungs Conference, in Edinburgh, UK from 6th to 8th December

  • 15 2023-11

    CPHI INDIA 2023

    We will be exhibiting at CPhI India in Dehli, India from 28th to 30th November 2023. Welcome to our stand 1C21.

  • 11 2023-07

    CPHI EUROPE 2023

    We will be participating in the CPHI exhibition in Barcelona, Spain from October 24 to October 26, 2023. Welcome to our booth 6A10 in Hall 6.0.

  • 12 2023-10

    Experts visited Shanghai Aurisco Biotech Co., Ltd.

    On Oct. 12, 2023, Wu Qi, Academician of the Chinese Academy of Sciences, polymer physical chemist, and Professor of the Chinese University of Hong Kong and University of Science and Technology of China, visited Shanghai Aurisco Biotech Co., Ltd..

  • 07 2023-09

    Experts visit Yangzhou Aurisco

    Academician Cheng Jinpei, a famous organic chemist and professor of Tsinghua University and Nankai University, visited Yangzhou Aurisco Pharmaceutical Co., Ltd..

  • 11 2023-08

    Successful FDA inspection at Yangzhou Aurisco

    Yangzhou, China, August 11th, 2023 – Aurisco Pharmaceutical announced today that its API and FDF plant in Yangzhou, China has successfully passed a cGMP inspection by the US Food and Drug Administration (USFDA).

  • 24 2023-07

    Aurisco will attend CPHI Korea 2023

    Aurisco will attend CPHI Korea, 30 August - 1 September 2023, COEX, Seoul, Korea. #booth at L-35 #

  • 16 2023-07

    Sirnaomics visited Yangzhou Aurisco

    Sirnaomics and Aurisco jointly explore opportunities and pathways to overcome challenges in the development and manufacturing of oligonucleotides, aiming to strengthening cooperation to accelerate the global launch of new oligonucleotides drugs.

  • 26 2023-06

    Aurisco gets Auxiton Approval.

    Aurisco Pharmaceutical’s Oral Dydrogesterone Tablets Get Marketing Authorization Approval in China Under The Brand Name AUXITON.

  • 27 2023-06

    Aurisco will Exhibit at CPHI South East Asia

    Aurisco will Exhibit at CPHI South East Asia 12-14 July 2023 ,Queen Sirikit NationaConvention CenterBangkok, Thailand. Stand at #D70#

  • 06 2023-05

    Aurisco will Exhibit at CPHI China 19-21 June 2023

    Aurisco will Exhibit at CPHI China 19-21 June 2023. Shanghai New International Expo Center. #booth at W2C02 #

  • 06 2023-04

    Aurisco will attend TIDES USA 2023 7 - 10 May 2023

    Aurisco will attend TIDES USA 2023 7 - 10 May 2023 San Diego, CA, USA

  • 04 2023-04

    Aurisco will attend RDD Europe 2023 2 - 5 May 2023

    Aurisco will participate in RDD Europe 2023 in Nice, France

  • 27 2023-02

    Aurisco will attend CPHI Japan 2023

    Aurisco will attend CPHI Japan, April 19th to 21st, 2023,Tokyo, Japan. #booth at 5N-16 #

  • 09 2023-01

    Aurisco will attend DCAT Week 2023 20-23 March

    Aurisco will attend DCAT Week 2023 20-23 March 2023. New York, USA

  • 09 2023-03

    Aurisco will attend RNA Leaders, March 15-16, 2023

    Aurisco will attend RNA Leaders, March 15-16, 2023, Basel Switzerland.

  • 08 2023-03

    AURISCO 25th YEAR ANNIVERSARY

    This year Aurisco turns 25 years old. Aurisco’s founder and chairman, Peng Zhien reflects on the company’s 25th anniversary, how it all started, the contribution of the business and what lies ahead.

  • 09 2023-01

    Aurisco will attend TIDES Asia

    Aurisco will attend TIDES Asia, March 3rd to 7th, 2023, Kyoto, Japan.

  • 03 2023-01

    Signing ceremony of Aurisco and Cytiva

    January 3,2023,Aurisco to build an Oligonucleotide FlexFactory™ for commercial cGMP production in cooperation with Cytiva.

  • 29 2022-12

    Aurisco will attend the 41st J.P.Morgan Healthcare

    Aurisco will attend the 41st J.P. Morgan Healthcare Conference 9-12 Jan 2023 San Francisco,CA,USA

  • 10 2022-11

    Aurisco will attend DDL 2022 7 - 9 December 2022.

    Aurisco will participate in DDL 2022 in Edinburgh, UK, from December 7 to 9, 2022. Edinburgh International Conference Centre.

  • 09 2022-11

    Aurisco will attend TIDES Europe 16 - 18 November

    Aurisco will attend TIDES Europe 16 - 18 November 2022. Austria Center Vienna.

  • 11 2022-07

    CPHI EUROPE 2022

    Aurisco is glad to announce our participance in CPHI Europe from Nov 1 to Nov 3. 2022. Aurisco 's entire team including our BD from US, EU is looking forward to meet our partners and friends , to present our new products , pipeline and CDMO service . Pls visit us at our booth (110H20, in hall no 11

  • 29 2022-01

    DCAT week 2022, let's meet !

    We are going to attend DCAT week in New York City on March 21-24, 2022, let's meet soon !  Our meeting room location : Benjamin Hotel .

  • 12 2021-07

    SHANGHAI AURISCO BIOTECHNOLOGY CO., ESTABLISHED

    Shanghai Aurisco Biotechnology Co., Ltd. was Established

  • 21 2020-09

    AURISO LISTED ON THE SHANGHAI STOCK EXCHANG

    On September 21, 2020, Aurisco Pharmaceutical Co., Ltd. (Stock code: 605116) was officially listed on the Shanghai Stock Exchange. The per share issuing price is RMB 8.37, number of shares issued is 41 million shares, raising a capital of RMB 343 millions.

  • 18 2019-04

    CPHI CHINA 2020

    We will participate in CPHI China 2020 from Dec. 16 to Dec. 18, 2020 . Welcome to visit our booth W2C02, in hall W2.

  • 18 2019-01

    CPHI JAPAN 2019

    We will participate in CPHI Japan from March 18 to March 20, 2019 . Welcome to visit our booth 2F-12

  • 01 2018-11

    CPHI EUROPE 2019

    We will participate in CPHI Europe 2019 from November 5 to November 7, 2019 . Welcome to visit our booth 42G12, in hall 4.2.

  • 11 2018-08

    CPHI EUROPE 2018

    We will participate in CPHI Europe 2018 in Madrid, Spain, from October 9 to October 11,  2018 in Madrid, Spain. Welcome to visit our booth 10B10, in hall 10.

  • 21 2020-09

    AURSICO LISTED ON THE SHANGHAI STOCK EXCHANG

    On September 21, 2020, Aurisco Pharmaceutical Co., Ltd. (Stock code: 605116) was officially listed on the Shanghai Stock Exchange. The per share issuing price is RMB 8.37 yuan, number of shares issued is 41 million shares, raising a capital of RMB 343 millions.

  • 18 2019-04

    CPHI CHINA 2020

    We will participate in CPHI China 2020 from Dec. 16 to Dec. 18, 2020 . Welcome to visit our booth W2C02, in hall W2.

  • 18 2019-01

    CPHI JAPAN 2019

    We will participate in CPHI Japan from March 18 to March 20, 2019 . Welcome to visit our booth 2F-12

  • 01 2018-11

    CPHI EUROPE 2019

    We will participate in CPHI Europe 2019 from November 5 to November 7, 2019 . Welcome to visit our booth 42G12, in hall 4.2.

  • 11 2018-08

    CPHI EUROPE 2018

    We will participate in CPHI Europe 2018 in Madrid, Spain, from October 9 to October 11,  2018 in Madrid, Spain. Welcome to visit our booth 10B10, in hall 10.

We use Cooke to allow the normal operation of our website, personalize the design of content and advertisements, provide social media functions and analyze traffic. We also share information about your use of our website with social media, advertising and analysis partners.

Accept Refuse